Julian S. Jehle
Bonn, NW 53127, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Unbiased assessment of 2-arachidonoylglycerol in cardiovascular inflammation.
Journal: Scientific reports
Published: September 15, 2025
Model order reduction techniques to identify submarining risk in a simplified human body model.
Journal: Computer methods in biomechanics and biomedical engineering
Published: January 10, 2023
Myeloid But Not Endothelial Expression of the CB2 Receptor Promotes Atherogenesis in the Context of Elevated Levels of the Endocannabinoid 2-Arachidonoylglycerol.
Journal: Journal of cardiovascular translational research
Published: March 29, 2022
Transverse aortic constriction-induced heart failure leads to increased levels of circulating microparticles.
Journal: International journal of cardiology
Published: October 01, 2021
Reply to "The endocannabinoid 2-arachidonoylglycerol inhibits endothelial function and repair through cannabinoid 1 (CB1) receptor".
Journal: International journal of cardiology
Published: December 16, 2020
Parameters predicting COVID-19-induced myocardial injury and mortality.
Journal: Life sciences
Published: August 20, 2020
The endocannabinoid 2-arachidonoylglycerol inhibits endothelial function and repair.
Journal: International journal of cardiology
Published: March 23, 2020
Atheroprotective effects of 17β-oestradiol are mediated by peroxisome proliferator-activated receptor γ in human coronary artery smooth muscle cells.
Journal: Archives of medical sciences. Atherosclerotic diseases
Published: January 30, 2020
Elevated levels of 2-arachidonoylglycerol promote atherogenesis in ApoE-/- mice.
Journal: PloS one
Published: December 22, 2017
Genetic disruption of multidrug resistance-associated protein 1 improves endothelial function and attenuates atherosclerosis in MRP1-/- LDLr-/- double knockout mice.
Journal: Archives of medical science : AMS
Published: July 13, 2016
Anti-atherosclerotic effects of serelaxin in apolipoprotein E-deficient mice.
Journal: Atherosclerosis
Published: February 06, 2016
Last Updated: 09/26/2026